Cargando…
Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
Autores principales: | Shen, Shi, Sewanan, Lorenzo R., Jacoby, Daniel L., Campbell, Stuart G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477869/ https://www.ncbi.nlm.nih.gov/pubmed/34096321 http://dx.doi.org/10.1161/JAHA.121.020860 |
Ejemplares similares
-
Titin Determines the Frank-Starling Relation in Early Diastole
por: Helmes, Michiel, et al.
Publicado: (2003) -
Simulation of the Frank-Starling Law of the Heart
por: Ribarič, Samo, et al.
Publicado: (2012) -
Lessons from the frank-starling curve
por: Bloria, Summit D
Publicado: (2021) -
The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications
por: Ráduly, Arnold Péter, et al.
Publicado: (2022) -
Looking for the inflexion point of the Frank-Starling curve
por: Aya, HD, et al.
Publicado: (2013)